Lithium prevents ouabain-induced behavioral changes: Toward an animal model for manic depression

Molecular and Chemical Neuropathology

Volumn 31, Issue 1, 1997, Pages 65-72

  Li, Rena ^a   El Mallakh, Rif S ^a   Harrison, Linda ^a   Changaris, David G ^a   Levy, Robert S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Bipolar disorder; cardiac glycosides; K ATPase; lithium; manic depressive disorder; Na; ouabain; sodium pump

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); LITHIUM; OUABAIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MANIC DEPRESSIVE PSYCHOSIS; MOTOR ACTIVITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALIA; STROPHANTHUS GRATUS;

EID: 0030752280     PISSN: 10447393     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02815161     Document Type: Article

References (15)

1. Batterman R. C. and Gutner L. B. (1948) Hitherto undescribed neurological manifestations of digitalis toxicity. Am. Heart J. 36, 582-586.
2. Changaris D. G., Porter J. L., Miller J. J., and Levy R. S. (1988) Des-Leu angiotensin I: biosynthesis and drinking response. Regul. Pept. 20, 273-280.
3. Christmas A. J. and Maxwell D. R. (1970) A comparison of the effects of some benzodiazepines and other drugs on aggressive and exploratory behaviour in mice and rats. Neuro-pharmacol. 9, 17-29.
4. Eisendrath S. T. and Sweeney M. A. (1987) Toxic neuropsychiatric effects of digoxin at therapeutic serum concentrations. Am. J. Psychiatry 144, 506-507.
5. El-Mallakh R. S., Barrett J. L., and Wyatt R. J. (1993a) The Na,K-ATPase hypothesis for bipolar disorder: Implications of normal development. J. Child Adolesc. Psychopharmacol. 3, 37-52.
6. El-Mallakh R. S., Harrison L. T., Changaris D. G., and Levy R. S. (1993b) An animal model for bipolar illness. Soc. Neurosci. Abstracts 340:18, 840.
7. El-Mallakh R. S., Harrison L. T., Li R., Changaris D. G., and Levy R. S. (1995a) An animal model for mania: Preliminary results. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 19, 955-962.
8. El-Mallakh R. S., Hedges S., and Casey D. (1995b) Digoxin encephalopathy presenting as mood disturbance. J. Clin. Psychopharmacol. 15, 82-83.
9. +-ATPase the link between phosphoinositide metabolism and bipolar disorder? J. Neuropsychiatry Clin. Neurosci. 5, 361-368.
10. El-Mallakh R. S. and Wyatt R. J. (1995) The Na,K-ATPase hypothesis for bipolar illness. Biol. Psychiatry 37, 235-244.
11. Goodwin F. K. and Jamison K. R. (1990) Manic-Depressive Illness. Oxford, New York.
12. Hayden J. F., Johnson L. R., and Maickel R. P. (1966) Construction and implantation of a permanent cannula for making injections into the lateral ventricle of the rat brain. Life Sci. 5, 1509-1515.
13. Levy R. S., El-Mallakh R. S., Li R., Harrison L. T., and Changaris D. G. (1995) An animal model for bipolar illness: Effects of lithium. Presented at the Sixth Annual Spring Brain Conference, March 1-5, Sedona, Az, Abstract No. 8.3.
14. Li R., Wing L. L., Wyatt R. J., and Kirch D. G. (1993) Effects of haloperidol, lithium, and valproate on phosphoinositide turnover in rat brain. Pharmacol. Biochem. Behav. 46, 323-329.
15. Looney S. W. and El-Mallakh R. S. (1995) A meta-analysis of Na,K-ATPase activity in bipolar illness. Presented at the Spring Meeting of the Biometric Society, March 26-29, Birmingham, AL.